Recombinant cells and methods for nonphosphorylative metabolism
AssigneeRegents of the University of Minnesota
InventorsKechun Zhang, Yi-shu Tai, Pooja Jambunathan
Life of this patent
Estimating the term…
Abstract
This disclosure describes methods for screening heterologous coding regions (e.g., a single gene coding region, and operon, or other gene cluster) for the ability to genetically modify a host cell to perform nonphosphorylative biosynthesis of 2,5-dioxopentanoate and downstream derivatives thereof (e.g., 1,4-butanediol, glutamate, or glutaconate. This disclosure further describes recombinant cells modified to increase nonphosphorylative biosynthesis of 2,5-dioxopentanoate compared to an appropriate control cell (e.g., a wild-type cell or an otherwise genetically-modified cell) and methods of using making and using such recombinant cells.
Claims35
A recombinant cell modified to exhibit increased biosynthesis of 2,5-dioxopentanoate compared to a wild-type control.
A recombinant cell comprising:
- at least one heterologous polynucleotide that encodes an enzyme in a nonphosphorylative biosynthetic pathway that converts D-xylose to 2,5-dioxopentanoate.
A recombinant cell comprising:
- at least one heterologous polynucleotide that encodes an enzyme in a nonphosphorylative biosynthetic pathway that converts L-arabinose to 2,5-dioxopentanoate.
Dependencies are inferred from the claim text.